COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1112: Articles 11111-11120  | Next

Should We Mitigate or Suppress the Next Pandemic? Time-Horizons and Costs Shape Optimal Social Distancing Strategies
Nowak, S. A., Lima, P. N. d., Vardavas, R.
10.1101/2021.11.14.21266322 — Posted: 2021-11-15
SARS-CoV-2 Mortality Surveillance among Community Deaths brought to University Teaching Hospital Mortuary in Lusaka, Zambia, 2020
Hamukale, A., Hines, J. Z., Sinyange, N., Fwoloshi, S., Malambo, W., Sivile, S., Chanda, S., Mucheleng'anga, L. A., Kayeyi, N., Himwaze, C. M., Shibemba, A., Leigh, T., Mazaba, M. L., Kapata, N., Zulu, P., Zyambo, K., Mupeta, F., Agolory, S., Mulenga, L. B., Malama, K., Kapina, M.
10.1101/2021.11.14.21266330 — Posted: 2021-11-15
Curating, collecting, and cataloguing global COVID-19 datasets for the aim of predicting personalized risk
Golriz Khatami, S., Francesca Russo, M., Domingo-Fernandez, D., Zaliani, A., Mubeen, S., Gadiya, Y., Sargsyan, A., Karki, R., Gebel, S., Ruppa Surulinathan, R. K., Lage-Rupprech, V., Archipovas, S., Mingrone, G., Jacobs, M., Claussen, C., Hofmann-apitius, M., Tom Kodamullil, A.
10.1101/2021.11.14.21265797 — Posted: 2021-11-15
CAN A MACHINE LEARNING ALGORITHM IDENTIFY SARS-COV-2 VARIANTS BASED ON CONVENTIONAL rRT-PCR? PROOF OF CONCEPT
cabrera Alvargonzalez, j., Larranaga Janeiro, A., Perez, S., Martinez Torres, J., martinez lamas, L., Davina Nunez, C., Del Campo Perez, V., Suarez Luque, S., Regueiro, B. J., Porteiro Fresco, J.
10.1101/2021.11.12.21266286 — Posted: 2021-11-15
The challenge of SARS-CoV-2 environmental monitoring in schools using floors and portable HEPA filtration units: Fresh or relic RNA?
Zuniga-Montanez, R., Coil, D. A., Eisen, J. A., Pechacek, R., Guerrero, R. G., Kim, M., Shapiro, K., Bischel, H. N.
10.1101/2021.11.12.21266178 — Posted: 2021-11-15
A live attenuated influenza virus-vectored intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 infection
Chen, J., Wang, P., Yuan, L., Zhang, L., Zhang, L., Zhao, H., Chen, C., Chen, Y., Han, J., Jia, J., Lu, Z., Hong, J., Chen, L., Fan, C., Lu, Z., Wang, Q., Chen, R., Cai, M., Qi, R., Wang, X., Ma, J., Zhou, M., Yu, H., Zhuang, C., Liu, X., Han, Q., Wang, G., Su, Y., Yuan, Q., Cheng, T., Wu, T., Ye, X., Li, C., Zhang, T., Zhang, J., Zhu, H., Chen, Y., Chen, H., Xia, N.
10.1101/2021.11.13.468472 — Posted: 2021-11-15
AI/ML Models to Aid in the Diagnosis of COVID-19 Illness from Forced Cough Vocalizations: Good Machine Learning Practice and Good Clinical Practices from Concept to Consumer for AI/ML Software Devices
Kelley, K., Kelley, M., Kelley, S. C., Sakara, A. A., Ramirez, M. A.
10.1101/2021.11.13.21266289 — Posted: 2021-11-15
Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
Hameedi, M. A., Teixeira Prates, E., Garvin, M. R., Mathews, I., Amos, B. K., Demerdash, O., Bechthold, M., Iyer, M., Rahighi, S., Kneller, D. W., Kovalevsky, A., Irle, S., Vuong, V.-Q., Mitchell, J. C., Labbe, A., Galanie, S., Wakatsuki, S., Jacobson, D.
10.1101/2021.11.11.468228 — Posted: 2021-11-15
Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2
Chen, I., Longbotham, J. E., McMahon, S., Suryawanshi, R., Carlson-Stevermer, J., Gupta, M., Zhang, M. Y., Soveg, F. W., Hayashi, J. M., Taha, T. Y., Lam, V. L., Li, Y., Yu, Z., Titus, E. W., Diallo, A., Oki, J., Holden, K., QCRG Structural Biology Consortium, , Krogan, N. J., Fijimori, D. G., Ott, M.
10.1101/2021.11.14.468537 — Posted: 2021-11-15
Full protection against all four SARS-CoV-2 variants of concern (VOC) in hamsters requires revision of spike antigen used for vaccination.
Sharma, S., Vercruysse, T., Sanchez-Felipe, L., Kerstens, W., Abdelnabi, R., Foo, C. S., Lemmens, V., Van Looveren, D., Maes, P., Baele, G., Weynand, B., Lemey, P., Neyts, J., Thibaut, H. J., Dallmeier, K.
10.1101/2021.11.12.468374 — Posted: 2021-11-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).